These medications are provided in partnership with a Food and Drug Administration-regulated 503B compounding pharmacy, the company said
Existing research shows that menstrual changes (like heavier bleeding) can increase iron loss, which plays an important role in transporting oxygen and energy production
In the meantime, CMS (Centers for Medicare & Medicaid Services) created two demonstration programs: Medicare GLP-1 Bridge (July 2026 to December 2027): A short-term program providing Medicare Part D beneficiaries access to select FDA-approved GLP-1 medications for obesity at a $50 monthly copay
Try habits like deep breathing, meditating, or gentle exercise to stay calm and focused
For Saxenda, patients can expect to pay between R2 500 and R4 000, depending on the dose
Member notification letters went out between August and November